TOLL vs. CANC

Last updated Jun 4, 2026

TOLL (Tema Monopolies and Oligopolies ETF) and CANC (Tema Oncology ETF) are both exchange-traded funds - TOLL is a Large Cap Growth Equities fund actively managed by Tema, while CANC is a Health & Biotech Equities fund actively managed by Tema. Both are actively managed. Over the past 3 years, TOLL returned 17.47%/yr vs 107.76%/yr for CANC. A 0.50 correlation means they provide meaningful diversification when combined. TOLL charges 0.55%/yr vs 0.75%/yr for CANC.

Performance

TOLL vs. CANC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema Monopolies and Oligopolies ETF (TOLL) and Tema Oncology ETF (CANC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TOLL achieves a 13.26% return, which is significantly higher than CANC's 4.82% return.

TOLL

• 1D: 0.58%
• 1M: 7.88%
• YTD: 13.26%
• 6M: 14.02%
• 1Y: 19.11%
• 3Y*: 17.47%
• 5Y*: —
• 10Y*: —

CANC

• 1D: 0.08%
• 1M: -3.73%
• YTD: 4.82%
• 6M: 3.86%
• 1Y: 47.37%
• 3Y*: 107.76%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

TOLL vs. CANC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
TOLL Tema Monopolies and Oligopolies ETF	13.26%	11.36%	12.79%	15.37%
CANC Tema Oncology ETF	4.82%	42.92%	-5.37%	787.60%

Correlation

The correlation between TOLL and CANC is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.45
Correlation (3Y) Calculated over the trailing 3-year period	0.51
Correlation (All Time) Calculated using the full available price history since May 12, 2023	0.50

The correlation between TOLL and CANC has been stable across timeframes, ranging from 0.45 to 0.51 - a consistent structural relationship.

TOLL vs. CANC - Sectors Allocation Comparison

Sectors	TOLL	CANC
Technology	32.0%	-
Financial Services	26.5%	-
Industrials	16.9%	-
Healthcare	12.7%	100.0%
Consumer Defensive	7.0%	-
Basic Materials	3.4%	-
Utilities	1.6%	-
Communication Services	-	-
Consumer Cyclical	-	-
Energy	-	-
Real Estate	-	-

Return for Risk

TOLL vs. CANC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TOLL

TOLL Risk / Return Rank: 38
TOLL Sharpe Ratio Rank: 38
TOLL Sortino Ratio Rank: 38
TOLL Omega Ratio Rank: 36
TOLL Calmar Ratio Rank: 35
TOLL Martin Ratio Rank: 41

CANC

CANC Risk / Return Rank: 69
CANC Sharpe Ratio Rank: 61
CANC Sortino Ratio Rank: 64
CANC Omega Ratio Rank: 54
CANC Calmar Ratio Rank: 90
CANC Martin Ratio Rank: 77

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TOLL vs. CANC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema Monopolies and Oligopolies ETF (TOLL) and Tema Oncology ETF (CANC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TOLL	CANC	Difference
Sharpe ratio: Return per unit of total volatility	1.35	2.06	-0.72
Sortino ratio: Return per unit of downside risk	1.96	2.96	-1.00
Omega ratio: Gain probability vs. loss probability	1.24	1.34	-0.10
Calmar ratio: Return relative to maximum drawdown	1.70	5.49	-3.78
Martin ratio: Return relative to average drawdown	6.49	14.62	-8.13
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TOLL vs. CANC - Sharpe Ratio Comparison

The current TOLL Sharpe Ratio is 1.35, which is lower than the CANC Sharpe Ratio of 2.06. The chart below compares the historical Sharpe Ratios of TOLL and CANC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	TOLL	CANC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.35	2.06	-0.72
Sharpe Ratio (All Time) Calculated using the full available price history	1.12	-0.04	+1.15

Drawdowns

TOLL vs. CANC - Drawdown Comparison

The maximum TOLL drawdown since its inception was -15.54%, smaller than the maximum CANC drawdown of -97.53%. Use the drawdown chart below to compare losses from any high point for TOLL and CANC.

Drawdown Indicators

	TOLL	CANC	Difference
Max Drawdown Largest peak-to-trough decline	-15.54%	-97.53%	+81.99%
Max Drawdown (1Y) Largest decline over 1 year	-11.26%	-8.67%	-2.59%
Max Drawdown (3Y) Largest decline over 3 years	-15.54%	-30.27%	+14.73%
Current Drawdown Current decline from peak	0.00%	-56.55%	+56.55%
Average Drawdown Average peak-to-trough decline	-2.39%	-73.19%	+70.80%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.95%	3.25%	-0.30%

Volatility

TOLL vs. CANC - Volatility Comparison

The current volatility for Tema Monopolies and Oligopolies ETF (TOLL) is 4.64%, while Tema Oncology ETF (CANC) has a volatility of 6.26%. This indicates that TOLL experiences smaller price fluctuations and is considered to be less risky than CANC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TOLL	CANC	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.64%	6.26%	-1.62%
Volatility (6M) Calculated over the trailing 6-month period	11.68%	16.69%	-5.01%
Volatility (1Y) Calculated over the trailing 1-year period	14.25%	23.11%	-8.86%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	15.82%	280.27%	-264.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	15.82%	280.27%	-264.45%

TOLL vs. CANC - Expense Ratio Comparison

TOLL has a 0.55% expense ratio, which is lower than CANC's 0.75% expense ratio.

Dividends

TOLL vs. CANC - Dividend Comparison

TOLL's dividend yield for the trailing twelve months is around 0.28%, more than CANC's 0.05% yield.

Position	TTM	2025	2024	2023
CANC Tema Oncology ETF	0.05%	0.06%	3.00%	0.56%
TOLL Tema Monopolies and Oligopolies ETF	0.28%	0.32%	1.99%	0.36%

Frequently Asked Questions

Can I hold both TOLL and CANC in my portfolio?

TOLL and CANC have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TOLL or CANC?

CANC has higher volatility (6.26%) compared to TOLL (4.64%). In terms of maximum drawdown, TOLL dropped -15.54% vs CANC's -97.53%.

Which ETF is better, TOLL or CANC?

On 3-year performance, CANC leads with 107.76% vs 17.47% for TOLL. On fees, TOLL is cheaper at 0.55% per year. On volatility, TOLL has been the lower-risk option at 4.64%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, TOLL or CANC?

Over the 3-year period, CANC has performed better with a 107.76% return vs 17.47%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, TOLL or CANC?

TOLL is cheaper with a 0.55% expense ratio, compared with 0.75% for CANC.

Which ETF pays a higher dividend yield, TOLL or CANC?

TOLL has the higher dividend yield at 0.28%, compared with 0.05% for CANC.

What is the main difference between TOLL and CANC?

TOLL is categorized as Large Cap Growth Equities, while CANC is Health & Biotech Equities. Their fees differ too: 0.55% for TOLL and 0.75% for CANC.

Which has better risk-adjusted returns?

CANC currently has the higher Sharpe Ratio (2.06 vs 1.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.